Abstract
Proximal tubal disease accounts for 10 ~ 25 % of tubal infertility. The underlying causes of tubal damage include pelvic inflammatory disease (PID), pelvic and abdominal surgery or endometriosis. Hysteroscopy and laparoscopy with chromopertubation (HLC) is considered as the “gold standard” for evaluating the integrity of the uterine cavity and for establishing tubal status. There are two treatment options for proximal tubal disease, namely, tubal surgery and in-vitro fertilisation (IVF). The success of surgical treatment depends on careful selection of cases. Tubal cannulation should be attempted prior to tubal anastomosis. Laparoscopy guided hysteroscopic tubal cannulation (LHTC) in women with proximal tubal block produces encouraging results regardless of whether one or both tubes are blocked. The overall pregnancy rate of LHTC is around 38 %. In women with proximal tubal block, LHTC and IVF are both effective treatment options.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
